The global panic of the novel coronavirus disease 2019 (COVID-19) triggered by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an urgent requirement …

The emergency state caused by COVID-19 saw the use of immunomodulators despite the
absence of robust research. To date, the results of relatively few randomized controlled trials …

The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …

In severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, viral load
peaks early and declines quickly after symptom onset. Severe coronavirus disease 2019 …

In the first year of its appearance, the 2019 coronavirus disease (COVID-19) has affected
more than 150 million individuals and killed 3 million people worldwide. The pandemic has …

BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic …

COVID-19 is an acute respiratory syndrome caused by SARS-COV-2 which has now
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …

The COVID-19 pandemic has inflicted millions of deaths worldwide. Despite the availability
of several vaccines and some special drugs approved for emergency use to prevent or treat …

With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain …

Abstract Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2),
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …